Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001120 · ClinicalTrials.gov registry record
A Study of Patients With AIDS Syndrome
A clinical trial of HIV Infections and Lymphoma, Non-Hodgkin, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 5,000
- Enrollment target
- 20
- Study locations
NCT00001120 is a study of HIV Infections and Lymphoma, Non-Hodgkin that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 5,000 participants, above the 437-participant average among 542 other HIV Infections trials with a reported enrollment target (1044% higher). The trial reports 20 study locations across 9 states.
The verdict
NCT00001120, a study of HIV Infections and Lymphoma, Non-Hodgkin, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 5,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to find out why cancers develop in HIV-positive patients. Cancer is a leading cause of death in AIDS patients. Common cancers in HIV-infected patients include Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), a cancer of the immune system. Risk factors include certain chemicals, viruses, and perhaps even anti-HIV drugs. Doctors would like to find out which risk factors are most important and how they relate to cancer in AIDS patients.
Conditions Studied
Study Locations (20)
California
- Willow Clinic - Menlo Park
- San Francisco Gen Hosp - San Francisco
- Marin County Specialty Clinic - San Rafael
- San Mateo AIDS Program / Stanford Univ - Stanford
- Stanford Univ Med Ctr - Stanford
New York
- SUNY / Erie County Med Ctr at Buffalo - Buffalo
- Bellevue Hosp / New York Univ Med Ctr - New York
- Mem Sloan - Kettering Cancer Ctr - New York
- St Mary's Hosp (Univ of Rochester/Infectious Diseases) - Rochester
- Univ of Rochester Medical Center - Rochester
Louisiana
- Charity Hosp / Tulane Univ Med School - New Orleans
- Tulane Univ School of Medicine - New Orleans
North Carolina
- Univ of North Carolina - Chapel Hill
- Duke Univ Med Ctr - Durham
Ohio
- Univ of Cincinnati - Cincinnati
- Case Western Reserve Univ - Cleveland
Hawaii
- Univ of Hawaii - Honolulu
Indiana
- Indiana Univ Hosp - Indianapolis
Maryland
- Johns Hopkins Hosp - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001120
The ClinicalTrials.gov registry entry for NCT00001120 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 437-participant average among 542 other HIV Infections trials with a reported enrollment target (1044% higher). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00001120 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, New York, Louisiana.
Frequently Asked Questions
What is clinical trial NCT00001120 about?
NCT00001120 is a clinical study titled "A Study of Patients With AIDS Syndrome". The purpose of this study is to find out why cancers develop in HIV-positive patients. Cancer is a leading cause of death in AIDS patients. Common cancers in HIV-infected patients include Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), a cancer of the immune system. Risk factors include cer...
What is the current status of trial NCT00001120?
This trial is currently completed. The enrollment target is 5,000 participants.
What conditions does trial NCT00001120 study?
This clinical trial studies the following conditions: HIV Infections, Lymphoma, Non-Hodgkin, Sarcoma, Kaposi, Lymphoma, AIDS-Related.
Who is sponsoring clinical trial NCT00001120?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001120 being conducted?
This trial has 20 study locations across California, Hawaii, Indiana, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.